Follow
yotsawat pomyen
yotsawat pomyen
Research Scientist, Chulabhorn Research Institute
Verified email at cri.or.th
Title
Cited by
Cited by
Year
MultiPhen: joint model of multiple phenotypes can increase discovery in GWAS
PF O’Reilly, CJ Hoggart, Y Pomyen, FCF Calboli, P Elliott, MR Jarvelin, ...
PloS one 7 (5), e34861, 2012
4112012
Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma
J Chaisaingmongkol, A Budhu, H Dang, S Rabibhadana, B Pupacdi, ...
Cancer cell 32 (1), 57-70. e3, 2017
3442017
Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
H Zheng, Y Pomyen, MO Hernandez, C Li, F Livak, W Tang, H Dang, ...
Hepatology 68 (1), 127-140, 2018
2742018
Oncogenic activation of the RNA binding protein NELFE and MYC signaling in hepatocellular carcinoma
H Dang, A Takai, M Forgues, Y Pomyen, H Mou, W Xue, D Ray, KCH Ha, ...
Cancer cell 32 (1), 101-114. e8, 2017
1302017
Genome-wide CRISPR screen identifies regulators of mitogen-activated protein kinase as suppressors of liver tumors in mice
CQ Song, Y Li, H Mou, J Moore, A Park, Y Pomyen, S Hough, Z Kennedy, ...
Gastroenterology 152 (5), 1161-1173. e1, 2017
1202017
Deep metabolome: Applications of deep learning in metabolomics
Y Pomyen, K Wanichthanarak, P Poungsombat, J Fahrmann, D Grapov, ...
Computational and Structural Biotechnology Journal 18, 2818-2825, 2020
1022020
Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells
C Koufaris, GN Valbuena, Y Pomyen, GD Tredwell, E Nevedomskaya, ...
Oncogene 35 (21), 2766-2776, 2016
682016
Understanding the cause and consequence of tumor heterogeneity
S Khatib, Y Pomyen, H Dang, XW Wang
Trends in cancer 6 (4), 267-271, 2020
342020
Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization
V Fako, SP Martin, Y Pomyen, A Budhu, J Chaisaingmongkol, S Franck, ...
International Journal of Biological Sciences 15 (12), 2654, 2019
222019
AGO2 Mediates MYC mRNA Stability in Hepatocellular Carcinoma
K Zhang, Y Pomyen, AE Barry, SP Martin, S Khatib, L Knight, M Forgues, ...
Molecular Cancer Research 18 (4), 612-622, 2020
172020
Over-representation of correlation analysis (ORCA): a method for identifying associations between variable sets
Y Pomyen, M Segura, TMD Ebbels, HC Keun
Bioinformatics 31 (1), 102-108, 2015
132015
NELFE-dependent MYC signature identifies a unique cancer subtype in hepatocellular carcinoma
H Dang, Y Pomyen, SP Martin, DA Dominguez, SY Yim, JS Lee, A Budhu, ...
Scientific reports 9 (1), 3369, 2019
122019
Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker
K Anekthanakul, S Manocheewa, K Chienwichai, P Poungsombat, ...
Iscience 24 (11), 2021
82021
Tumor metabolism and associated serum metabolites define prognostic subtypes of Asian hepatocellular carcinoma
Y Pomyen, A Budhu, J Chaisaingmongkol, M Forgues, H Dang, ...
Scientific Reports 11 (1), 12097, 2021
72021
Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis
S Chujan, T Suriyo, T Ungtrakul, Y Pomyen, J Satayavivad
Biomedical Reports 9 (1), 42-52, 2018
52018
Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
Y Pomyen, J Chaisaingmongkol, S Rabibhadana, B Pupacdi, D Sripan, ...
Scientific Reports 13 (1), 11406, 2023
42023
Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma
J Chaisaingmongkol, A Budhu, H Dang, S Rabibhadana, B Pupacdi, ...
Cancer 1, 2018
12018
Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma
Z Kacar, E Slud, D Levy, J Candia, A Budhu, M Forgues, X Wu, ...
Communications Biology 7 (1), 383, 2024
2024
Plasma metabolite biomarkers for EGFR-mutated non-small cell lung cancer (NSCLC)
L Thamlikitkul, S Manocheewa, S Limjiasahapong, K Wanichthanarak, ...
Cancer Research 84 (6_Supplement), 1068-1068, 2024
2024
Genomic landscape in Saudi patients with hepatocellular carcinoma using whole-genome sequencing: a pilot study
D Sharma, Y Pomyen, M Abedalthagafi, M Hassanain, Y Liu, W Hussain, ...
2023
The system can't perform the operation now. Try again later.
Articles 1–20